Video - European Medical Journal

Continue

Videos

EMJ
Oncology
24 Apr 2015

The current biosimilar landscape

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Paul Declerck (KU Leuven, Leuven, Belgium) discusses the understanding of the…
EMJ
Oncology
24 Apr 2015

Biosimilars for breast cancer treatment

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges…
EMJ
Oncology
24 Apr 2015

CDK 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Richard Finn (UCLA, Los Angeles, CA) discusses the development of the cyclin…
EMJ
Oncology
24 Apr 2015

Ki67 as a marker for making management decisions in breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr John Bartlett (Ontario Institute for Cancer Research, Toronto, Canada) discusses…
EMJ
Oncology
24 Apr 2015

New drugs in neoadjuvant breast cancer therapy

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Sibylle Loibl (German Breast Group, Neu-Isenburg, Germany) discusses recent…
EMJ
Oncology
24 Apr 2015

Are randomised trials obsolete or more important than ever?

At the 14th St. Gallen International Breast Cancer Conference (SG-BCC) 2015, Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) Dr…
EMJ
Oncology
14 Apr 2015

An Interview with Prof. Dmitry Pushkar at EAU 2015

Prof. Dmitry Pushkar discusses the European Association of Urology congress 2015, the future of congress and the benefits of health journals.
EMJ
Oncology
14 Apr 2015

Immune pathways and immunome as targets for breast cancer treatment

Dr Giuseppe Curigliano (European Institute of Oncology, Milan, Italy) provides an overview of immune approaches for the treatment of breast cancer at the…